The Government’s leading body for Covid19 drug trials – led by the controversial character Professor Peter Horby – stands accused of grossly misleading negative trial results for the coronavirus management drug Hydroxychloroqhine. Will this at last be a wake-up call for Boris Johnson?
The lead story in today’s France Soir – a long-respected and unaligned French daily – presents compelling evidence to suggest that the Whitehall/Cabinet Covid19 “advice” team cannot be trusted….and raises yet more doubts about BBC complicity in a false Coronavirus narrative.
Last May 10th, The Slog wrote a scathing critique of the interview given by ‘Recovery’ boss Professor Peter Horby on the Marr Show. Subsequent events would appear to be proving my analysis correct.
Professor Peter Horby is an epidemiologist, and the Professor of Emerging Infectious Diseases and Global Health at the University of Oxford. He chairs the UK government’s New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG). In addition, seven weeks ago he was charged with leading the ‘Recovery’ trial team into drugs for COVID-19.
It obviously goes without saying that, given the tentacular influence of the Big Pharma lobying and ‘research’ funding army, a person in such a position must be seen to have total command of the science involved, and be beyond reproach when it comes to commercial conflicts of interest. As this site has already established, two months ago, his Oxford department announced an agreement with the UK-based global biopharmaceutical company AstraZeneca for the further development, large-scale manufacture and potential distribution of the COVID-19 vaccine candidate currently being trialled by the University.